-
-
-
7 . Periodical
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
- 저자
- by Petrylak, Daniel P; de Wit, Ronald; Chi, Kim N; Drakaki, Alexandra; Sternberg, Cora N, et al.
- 소스
- The Lancet; November 2017, Vol. 390 Issue: 10109 p2266-2277, 12p